BCWORLD PHARM. CO., LTD. Toevoegen aan een lijst
|
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 5.790 KRW | +0,17% |
|
-4,61% | -10,37% |
Totale waarde
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 172.278 | 121.692 | 201.510 | 135.336 | 71.475 | 54.513 |
| Bedrijfswaarde 1 | 217.039 | 176.123 | 265.288 | 219.855 | 157.672 | 135.188 |
| K/w-verhouding | 34,5 x | -78,5 x | -127 x | -91,5 x | 257 x | 20,7 x |
| Dividendrendement | 0,45% | 0,63% | 0,42% | 0,63% | 1,18% | 1,55% |
| Marktkapitalisatie/omzet | 3,14 x | 2,36 x | 3,53 x | 2,18 x | 0,98 x | 0,73 x |
| Bedrijfswaarde/omzet | 3,96 x | 3,42 x | 4,65 x | 3,54 x | 2,17 x | 1,8 x |
| Bedrijfswaarde/EBITDA | 24,4 x | 66,4 x | 107 x | 60,1 x | 17,4 x | 9,77 x |
| Bedrijfswaarde/FCF | -15,5 x | -11,7 x | -22,6 x | -3,54 x | -63,2 x | 25,9 x |
| FCF Yield | -6,44% | -8,51% | -4,43% | -28,3% | -1,58% | 3,86% |
| Price to Book | 1,99 x | 1,42 x | 2,39 x | 1,65 x | 0,9 x | 0,67 x |
| Aantal aandelen (in duizenden) | 8.460 | 8.422 | 8.539 | 8.539 | 8.439 | 8.439 |
| Referentieprijs 2 | 20.364 | 14.450 | 23.600 | 15.850 | 8.470 | 6.460 |
| Datum van publicatie | 7/03/19 | 6/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Omzet 1 | 54.792 | 51.497 | 57.030 | 62.079 | 72.703 | 75.111 |
| EBITDA 1 | 8.909 | 2.654 | 2.473 | 3.655 | 9.070 | 13.835 |
| Bedrijfsresultaat (EBIT) 1 | 5.601 | -1.005 | -2.096 | -1.798 | 1.862 | 6.365 |
| Operationele Marge | 10,22% | -1,95% | -3,68% | -2,9% | 2,56% | 8,47% |
| Resultaat voor belastingen (EBT) 1 | 5.487 | -2.572 | -2.830 | -2.000 | -1.523 | 1.206 |
| Nettowinst (verlies) 1 | 4.993 | -1.553 | -1.580 | -1.478 | 281,3 | 2.634 |
| Nettomarge | 9,11% | -3,02% | -2,77% | -2,38% | 0,39% | 3,51% |
| WPA 2 | 590,2 | -184,0 | -185,7 | -173,1 | 33,01 | 312,1 |
| Free Cash Flow 1 | -13.968 | -14.992 | -11.755 | -62.122 | -2.496 | 5.224 |
| FCF-marge | -25,49% | -29,11% | -20,61% | -100,07% | -3,43% | 6,95% |
| Kasstroomconversie (ebitda) | - | - | - | - | - | 37,76% |
| Kasstroomconversie (nettowinst) | - | - | - | - | - | 198,34% |
| Dividend per aandeel 2 | 90,91 | 90,91 | 100,0 | 100,0 | 100,0 | 100,0 |
| Datum van publicatie | 7/03/19 | 6/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 44.760 | 54.431 | 63.777 | 84.518 | 86.197 | 80.675 |
| Nettokaspositie 1 | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 5,024 x | 20,51 x | 25,79 x | 23,12 x | 9,503 x | 5,831 x |
| Free Cash Flow 1 | -13.968 | -14.992 | -11.755 | -62.122 | -2.496 | 5.224 |
| ROE (netto-inkomsten/eigen vermogen) | 5,91% | -2,02% | -2,59% | -2,73% | 0,08% | 3,68% |
| ROA (netto-inkomsten/totale activa) | 2,53% | -0,39% | -0,77% | -0,62% | 0,64% | 2,17% |
| Totale activa 1 | 197.342 | 396.420 | 204.449 | 238.098 | 43.809 | 121.541 |
| Nettoactief per aandeel 2 | 10.213 | 10.206 | 9.857 | 9.633 | 9.427 | 9.675 |
| Cashflow per aandeel 2 | 283,0 | 200,0 | 1.251 | 323,0 | 478,0 | 829,0 |
| Capex 1 | 29.916 | 21.318 | 7.785 | 17.459 | 6.217 | 2.577 |
| Capex/omzet | 54,6% | 41,4% | 13,65% | 28,12% | 8,55% | 3,43% |
| Datum van publicatie | 7/03/19 | 6/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Historische marktkapitalisatie/EBITDA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -10,37% | 35,33 mln. | |
| +15,91% | 41,97 mld. | |
| +22,40% | 22,34 mld. | |
| +18,48% | 15,25 mld. | |
| +16,12% | 14 mld. | |
| +45,12% | 12,06 mld. | |
| -9,58% | 6,8 mld. | |
| -0,05% | 6,79 mld. | |
| -8,87% | 5,73 mld. | |
| +14,18% | 5,49 mld. |
- Beurs
- Aandelen
- Koers A200780
- Financiën BCWORLD PHARM. Co., Ltd.
